Répertoire des subventions financées

Filtrer par

727 ésultat(s) trouvé(s)

The SLEEP HUB: an open science ecosystem for transforming sleep research

  • Type de subvention

    Platform grants

  • Domaine de recherche

    Multiple

  • Disease Area

    Other

  • Compétition

    2024 Platform Support Grants

  • Province

    Québec

  • Date de Début

    2025

  • Montant total du financement

    $2,137,500

  • Contribution Santé Canada

    $1,068,750

Aperçu du projet

The SLEEP HUB is an innovative platform aimed at advancing sleep research and fostering collaborations at various levels—local, national, and international. Developed by the Centre for Advanced Research in Sleep Medicine (CARSM) located in Montreal, it integrates three key resources: the Nights Bank, the Canadian Sleep Research Biobank, and the…

The NECTAr platform: A pan-Canadian platform dedicated to Neonatal hypoxic-ischemic Encephalopathy — For patient Care optimization, Training, and educAtion

  • Type de subvention

    Platform grants

  • Domaine de recherche

    Neurodevelopment

  • Disease Area

    Other

  • Compétition

    2024 Platform Support Grants

  • Province

    Québec

  • Date de Début

    2025

  • Montant total du financement

    $1,710,000

  • Contribution Santé Canada

    $855,000

Aperçu du projet

At birth, some babies suffer from a condition called birth asphyxia, where their brain and organs do not receive enough oxygen or blood, leading to hypoxic-ischemic encephalopathy (HIE). This life-threatening condition is responsible for 23% of babies’ deaths worldwide and often results in cerebral palsy and difficulties with learning and…

Novel biological agents in the treatment of amyotrophic lateral sclerosis based on progranulin/granulin structure

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    ALS

  • Compétition

    CQDM-Brain Canada Call for Collaborative Research Projects on the Brain

  • Province

    Québec

  • Date de Début

    2025

  • Montant total du financement

    $814,900

  • Contribution Santé Canada

    $407,450

Aperçu du projet

Challenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease. Our challenge is to develop a biologic-therapy that slows, halts or functionally reverses ALS progression. Solution: ALS is characterized by the toxic mislocalization of a hyperphosphorylated form of TAR DNA binding protein-43 (TDP-43) within MNs.…

Connecting cellular signalling data with behavioural and clinical outcomes for 5-HT receptor ligands

  • Domaine de recherche

    Mental Health

  • Disease Area

    Mental illness

  • Compétition

    CQDM-Brain Canada Call for Collaborative Research Projects on the Brain

  • Province

    Québec

  • Date de Début

    2025

  • Montant total du financement

    $500,000

  • Contribution Santé Canada

    $250,000

Aperçu du projet

The Challenge: Current therapies for treating a number of mental health disorders – depression, anxiety, and PTSD, among them – adequately treat only a small fraction of afflicted patients. Promising new targets, despite strong rationales, have not improved this picture. As ketamine provided more than two decades ago, a breakthrough…

Elatus: Chronically Implantable Unit-Scale Microelectrode Array Neuromodulation Technology

  • Domaine de recherche

    Saisie

  • Disease Area

    Epilepsy

  • Province

    Québec

  • Date de Début

    2025

  • Montant total du financement

    $1,657,750

  • Contribution Santé Canada

    $828,875

Aperçu du projet

Challenge: Current DRE standard of care is either DBS (Medtronic, Boston Scientific), Vagus Nerve Stimulation (VNS - Livanova) or Responsive Nerve Stimulation (RNS - NeuroPace). These devices rarely eliminate seizures, and there is little to differentiate them from one another. Typically, median seizure reduction is 50-70% which, while statistically significant,…